Not yet activatedNot yet activated

Fructo-oligosaccharides / galacto-oligosaccharides

Overview

This page is the combined fructo-oligosaccharide and galacto-oligosaccharide preparation used in one human fermentation study. It is not a licence to treat every FOS, every GOS, and oligofructose as the same substance. Oligofructose is a defined short-chain inulin-type mixture. Sucrose-derived fructooligosaccharides are another preparation. Galacto-oligosaccharides are built from galactose, not fructose.

In people, that combined oligosaccharide preparation was fermented in the intestine and supplied carbohydrate for microbial short-chain fatty acid formation [1]. The fate of those acids was measured for the administered mixture. The result is not attributed to fructo-oligosaccharides alone or to galacto-oligosaccharides alone, and it is not ordinary-food equivalence [1].

Dietary Origin

The exposure is the administered combination [1]. A food that contains some fructan, or a supplement labelled only FOS or only GOS, is not identified as this mixture. Oligofructose from chicory inulin hydrolysate is a different material and has its own page. No food page is linked.

Research Spotlights & Evidence Checks

🔎 Evidence Check · combination-formulation

Can the combined FOS/GOS result be assigned to GOS alone, or to oligofructose?

No. Intestinal fermentation and short-chain fatty acid fate were measured for the administered fructo- plus galacto-oligosaccharide preparation [1].

Read the evidence

The human study followed intraintestinal fermentation of fructo- and galacto-oligosaccharides together [1]. Splitting that result into a pure GOS effect, a pure FOS effect, or an oligofructose effect would go beyond the preparation that was given. Oligofructose remains the short-chain inulin-type mixture on its own page.

Recipes

no recipes found (no foods contain this substance)

Foods

no foods found

Biological Regulatory Systems

Biological Regulatory System	Evidence-qualified relationship	Evidence
Gut-Brain Axis & Enteric Nervous System (BRS5)	The combined preparation supplies carbohydrate for microbial short-chain fatty acid formation in SCFA production and signalling. The result stays with the mixture.	[1]

References

[1] van Trijp et al. (2024). Intraintestinal fermentation of fructo- and galacto-oligosaccharides and the fate of short-chain fatty acids in humans. The administered combination supplied carbohydrate for microbial short-chain fatty acid formation, and the study followed the fate of those acids. Not evidence for either oligosaccharide alone, and not ordinary-food equivalence.

BRS matrix — individual KC inputs

BRS / PM	Relationship	Biological role and limitation
BRS5 · BRS5-FM1-PM1 BRS5(KC1)	Supported upstream supply	The tested FOS/GOS preparation supplies microbial fermentation substrates upstream of epithelial barrier biology. Limitation: Controlled human FOS/GOS fermentation does not establish the effects of inulin alone, individual FOS or GOS, ordinary food portions, or human tight-junction improvement. van Trijp et al. (2024) [11]